Related references
Note: Only part of the references are listed.OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody
Hirofumi Ohmura et al.
BRITISH JOURNAL OF CANCER (2020)
Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition
Andressa S. Laino et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)
Takashi Matsuzuka et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
Monitoring the neutrophil-to-lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer
Ryuji Yasumatsu et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis
Zhenhua Liu et al.
BMC CANCER (2019)
C-Reactive Protein-to-Albumin Ratio as Prognostic Marker for Anal Squamous Cell Carcinoma Treated With Chemoradiotherapy
Daniel Martin et al.
FRONTIERS IN ONCOLOGY (2019)
Prognostic value of C-reactive protein/albumin ratio for patients with hypopharyngeal and laryngeal cancer undergoing invasive surgery involving laryngectomy
Akihito Kuboki et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment
Hirotake Tsukamoto et al.
CANCER RESEARCH (2018)
Association Between Pretreatment Neutrophil-to-Lymphocyte Ratio and Outcome of Patients With Metastatic Renal-Cell Carcinoma Treated With Nivolumab
Mehmet Asim Bilen et al.
CLINICAL GENITOURINARY CANCER (2018)
Analysis of Early Death in Japanese Patients With Advanced Non-small-cell Lung Cancer Treated With Nivolumab
Takako Inoue et al.
CLINICAL LUNG CANCER (2018)
Cancer-associated cachexia
Vickie E. Baracos et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Prognostic Markers in Head and Neck Cancer Patients Treated with Nivolumab
Daisuke Nishikawa et al.
CANCERS (2018)
Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab
Stefan Diem et al.
LUNG CANCER (2017)
Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer
Stephen J. Bagley et al.
LUNG CANCER (2017)
Basal neutrophil-to-lymphocyte ratio is associated with overall survival in melanoma
Leonardo S. Lino-Silva et al.
MELANOMA RESEARCH (2017)
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang et al.
NATURE (2017)
Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma
Shi-tong Yu et al.
ONCOTARGETS AND THERAPY (2017)
Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling
Kristine Pettersen et al.
SCIENTIFIC REPORTS (2017)
Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer
Mitsuru Ishizuka et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The C-reactive Protein to Albumin Ratio Predicts Long-Term Outcomes in Patients with Pancreatic Cancer After Pancreatic Resection
Koichiro Haruki et al.
WORLD JOURNAL OF SURGERY (2016)
A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio
Xiao-li Wei et al.
BMC CANCER (2015)
Immunology and Immunotherapy of Head and Neck Cancer
Robert L. Ferris
JOURNAL OF CLINICAL ONCOLOGY (2015)
Inflammation and cancer: advances and new agents
Shanthini M. Crusz et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer
Xuechao Liu et al.
TRANSLATIONAL ONCOLOGY (2015)
Ratio of C-Reactive Protein/Albumin is An Inflammatory Prognostic Score for Predicting Overall Survival of Patients with Small-cell Lung Cancer
Ting Zhou et al.
SCIENTIFIC REPORTS (2015)
The C-Reactive Protein/Albumin Ratio, a Novel Inflammation-Based Prognostic Score, Predicts Outcomes in Patients with Hepatocellular Carcinoma
Akiyoshi Kinoshita et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma
Xiao-Ling Xu et al.
PLOS ONE (2015)
The role of the PD-L1: PD-1 pathway in squamous cell carcinoma of the head and neck
Dan P. Zandberg et al.
ORAL ONCOLOGY (2014)
Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients
Praveen Ravishankaran et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Interleukin-6 predicts recurrence and survival among head and neck cancer patients
Sonia A. Duffy et al.
CANCER (2008)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer
DJ McKeown et al.
BRITISH JOURNAL OF CANCER (2004)
Serum interleukin-6 levels reflect the disease status of colorectal cancer
YC Chung et al.
JOURNAL OF SURGICAL ONCOLOGY (2003)
Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma
N Yoshida et al.
BRITISH JOURNAL OF CANCER (2002)
IL-6-like cytokines and cancer cachexia - Consequences of chronic inflammation
BE Barton
IMMUNOLOGIC RESEARCH (2001)
Share Paper
